Journal of Commercial Biotechnology — July 2008

The March 2008 issue of the Journal of Commercial Biotechnology is now available. This issue focuses on biotechnology marketing and was guest-edited by Leyland Pitt and Ian McCarthy. The links below will take you to the abstract of each article:
Volume 14, Issue 3
Editorial
Leyland Pitt and Ian McCarthy
New pharmaceutical product development: Barriers to overcome and opportunities to exploit
Nic S Terblanche
The [...]

Looking for writers for book projects

Looking for writers for two book projects:
1) Convert a 102 page screenplay into a book. The topic is the development of a biotechnology company. Looking for a creative non-fiction writer who can write a compelling story. The CEO is available for input and is actively interested in developing the book, but has very limited time [...]

Drug Patent Expirations in July 2008

Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in July 2008
*Drugs may be covered by multiple patents

Tradename
Applicant
Generic Name
Patent Number
Patent Expiration

CARDIOLITE
Bristol Myers Squibb
technetium tc-99m sestamibi kit
4,988,827
Jul 29, 2008

DEPAKOTE
Abbott
divalproex sodium
4,988,731
Jul 29, 2008

DEPAKOTE
Abbott
divalproex sodium
5,212,326
Jul 29, 2008

DEPAKOTE CP
Abbott
divalproex sodium
4,988,731
Jul 29, 2008

DEPAKOTE CP
Abbott
divalproex sodium
5,212,326
Jul 29, 2008

DEPAKOTE ER
Abbott
divalproex sodium
4,988,731
Jul 29, 2008

DEPAKOTE ER
Abbott
divalproex sodium
5,212,326
Jul 29, 2008

GLUCOTROL XL
Pfizer
glipizide
5,545,413
Jul 2, 2008

HIVID
Roche
zalcitabine
5,028,595
Jul 2, 2008

RESTORIL
Tyco Hlthcare
temazepam
5,030,632
Jul 9, 2008

RESTORIL
Tyco Hlthcare
temazepam
5,326,758
Jul [...]

Dyadic founder regains control

After an extended struggle Mark Emalfarb, the founder of Dyadic has regained control of the firm. He was originally ousted by the board after an accounting scandal at a foreign subsidiary. By forming a coalition with other shareholders, representing a majority of the company’s shares, Emalfarb was able to dismiss the board members who had [...]

Six Pitfalls to Avoid in Supplier Management

Guest content from John Avellanet, managing director and principal of Cerulean Associates:

Managing suppliers is fraught with challenges. Rare is the executive who has not made a mistake. In this article, I look at some of the most common mistakes—most of which I’ve made myself—and how to avoid them.

Reminder: BIO2008 Session

For those attending BIO2008, I’ll be speaking on Friday morning:
Title: Scientific Communications – Trends and Liabilities
Track: Public Relations/Investor Relations
Date and Time: Friday, June 20 9:00 AM – 10:30 AM
Hope to see you there!